Digital Pathology Market

November 2016 | 156 pages | ID: D3E1E9C1EBDEN
Progressive Markets (owned by Antviews Global)

Abstracts

Digital Pathology Market Overview

Digital Pathology Market is projected to garner revenue worth $1,694 million by 2022 at a CAGR of 17.6% during 2017-2025. Digital pathology is an emerging technology in the pathology field, in which the glass slides are converted into digital images for easy viewing, analysis, storage, and management of the collected data. This advancement will shift the conventional pathology to an advanced level. Digitalization of pathology has led to the automation of the tests during diagnosis that resulted in saving cost and efforts. For instance, a single digital instrument can perform tests that were previously performed using five instruments by pathologists.

The growth of the market is attributed to factors such as efficient cost of digital pathology products, ease of transportation of slides virtually, high efficiency of digital pathology systems, and efficient analysis of digital slides. In addition, increased adoption of digital pathology over conventional pathology treatments drives the market. On the other hand, barriers such as lack of reimbursement and skilled personnel are some of the major factors likely to restrain the market growth. However, rising initiatives towards commercialization of cost-efficient digital pathology systems would offer profitable growth opportunities for the service providers in the future.

The world digital pathology market is segmented on the basis of product, end users, and geography. Based on product, the market is further segmented into whole slide imaging (WSI), image analysis informatics, information management system storage & communication, and others. Whole slide imaging is the highest revenue-generating segment as it is the most preferred method used to produce digital slides by scanning the whole glass slide. This segment is projected to grow at a CAGR of 14.4% during the study period. By end user, the market is segmented into educational institutes, hospitals and diagnostic centers, and pharmaceutical & biotechnology companies. Hospitals & diagnostic centers and pharmaceutical & biotechnology segments collectively accounted for more than 70% of the market share in 2015. In terms of geography, the market is segmented into North America, Europe, Asia-Pacific, and LAMEA. Asia Pacific and LAMEA together accounted for about 20% of the market in 2015.

In the current scenario, companies are adopting collaborations, product launches, and agreements as their key development strategies in the digital pathology market. For instance, Visiopharm, in collaboration with LRI Imaging and Inter Instrument AS entered into a partnership to deploy DP systems throughout Scandinavia. The key companies profiled in the report are Visiopharm, Indica Labs, Digipath Inc., Koninklinje Philips N. V., Hamamatsu Photonics K. K., PerkinElmer, Inc., Danaher Corporation (Leica Microsystem), Nikon Corporation, Pixcelldata Ltd., Glencoe Software Inc., and Definiens AG.

KEY BENEFITS FOR STAKEHOLDERS:

• This report provides an extensive analysis of the current and emerging trends and dynamics in the world digital pathology market.
• The research offers a detailed analysis of the current market and estimations from 2014 to 2022 are made, which would enable businesses & stakeholders to capitalize on the prevailing opportunities.
• The digital pathology market scenario is comprehensively analyzed in accordance to key geographical regions.
• The key players are profiled in the report and their strategies are thoroughly analyzed to determine the competitive outlook of the market.
• SWOT analysis enables to study the internal environment of the leading companies for strategy formulation.

DIGITAL PATHOLOGY MARKET KEY SEGMENTS:

• Market - by Product
• Whole Slide Imaging
• Image Analysis - Informatics
• Information Management System Storage & Communication
• Others
• Market - by End User
• Educational Institutes
• Hospitals and diagnostic centers
• Pharmaceutical & biotechnology companies
• Market - by Geography
• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Asia-Pacific
• Japan
• China
• Australia
• India
• South Korea
• Taiwan
• Others
• LAMEA
• Brazil
• Turkey
• Venezuela
• Saudi Arabia
• Colombia
• Argentina
• Others

Contents

CHAPTER 1 INTRODUCTION

1.1 Report description
1.1 Key benefits
1.2 Key market segments
1.3 Key audiences
1.4 Research methodology
  1.4.1 Secondary research
  1.4.2 Primary research
  1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective
2.2 Market beyond: what to expect by 2027
  2.2.1 Base case scenario
  2.2.2 Rapid growth scenario
  2.2.3 Diminishing growth scenario

CHAPTER 3 GLOBAL MARKET OVERVIEW

3.1 Market definition and scope
3.2 Introduction
3.3 Conventional pathology vs. digital pathology
3.4 Image analysis and data retrieval
3.5 Management systems in digital pathology
3.6 Global access to data
3.7 Clinical trials using digital pathology
3.8 Information systems in digital pathology
3.1 Key findings
  3.1.1 Top winning strategies
  3.1.2 Top investment pockets
    3.1.2.1 digital pathology market by product
    3.1.2.2 digital pathology market by end user
3.2 Porter’s five forces analysis
  3.2.1 Competition reduces the power of the suppliers
  3.2.2 Availability of wide range of products enhances the buyer’s power
  3.2.3 Emerging market creates high competition
  3.2.4 Cost factor lowers the threat of new entrants
  3.2.5 High cost encourages substitution
3.3 Regulatory issues
3.4 Reimbursement scenario
3.5 Case study
  3.5.1 Case study 1: Digital pathology used in critical diagnosis
  3.5.2 Case study 2: Examples and initiatives of deploying telepathology in emerging economies
  3.5.3 Case study 3: Role of digital pathology in saving cost of pharma companies
3.6 Market dynamics
  3.6.1 Drivers
    3.6.1.1 Use of digital pathology in cancer diagnosis
    3.6.1.2 Cost-efficiency
    3.6.1.3 Ease in transportation
    3.6.1.4 High efficiency
    3.6.1.5 Efficient analysis
    3.6.1.6 System efficiency
    3.6.1.7 Efficiency in workflow
    3.6.1.8 Diagnosis in remote regions
  3.6.2 Restraints
    3.6.2.1 Lack in reimbursement
    3.6.2.2 Lack of infrastructure in developing economies
    3.6.2.3 Resistance towards adoption of digital pathology
  3.6.3 Opportunities
    3.6.3.1 Opportunities from emerging economies
    3.6.3.2 Rising awareness pertaining to digital pathology
    3.6.3.3 Increasing potential of digital pathology

CHAPTER 4 GLOBAL DIGITAL PATHOLOGY MARKET, BY PRODUCTS

4.1 Global digital pathology market, by product
4.2 Whole slide imaging (WSI)
  4.2.1 Global Digital Pathology whole slide imaging market, by product
  4.2.2 Global digital pathology whole slide imaging market
4.3 Image analysis—informatics
  4.3.1 Drivers
    4.3.1.1 Helps in decision making
    4.3.1.2 Automation to analyze Multitude of images
    4.3.1.3 Compare image data with other data
    4.3.1.4 study complex morphologies and features
  4.3.2 Global digital pathology image analysis—informatics market
4.4 Storage, communication, and information management systems
  4.4.1 Global digital pathology information management system, storage, & communication market
4.5 Others
  4.5.1 Global digital pathology others market, by geography

CHAPTER 5 DIGITAL PATHOLOGY MARKET, BY END USER

5.1 Global digital pathology market, by end user
5.2 Pharmaceutical and biotechnology companies
  5.2.1 Global digital pathology pharmaceutical research market
5.3 Hospitals and diagnostic centers
  5.3.1 Global digital pathology clinical organizations market
5.4 Educational institutes
  5.4.1 Global digital pathology educational institutes market

CHAPTER 6 GLOBAL DIGITAL PATHOLOGY MARKET BY GEOGRAPHY

6.1 Overview
6.2 North America
  6.2.1 North America digital pathology market
  6.2.2 U.S. market size and forecast
  6.2.3 Canada market size and forecast
  6.2.4 Mexico market size and forecast
6.3 Europe
  6.3.1 Europe digital pathology market
  6.3.2 Germany market size and forecast
  6.3.3 France market size and forecast
  6.3.4 U.K. market size and forecast
  6.3.5 Italy market size and forecast
  6.3.6 Spain market size and forecast
  6.3.7 Russia market size and forecast
  6.3.8 Other Europe market size and forecast
6.4 Asia-Pacific
  6.4.1 Asia-Pacific digital pathology market
  6.4.2 Japan market size and forecast
  6.4.3 China market size and forecast
  6.4.4 Australia market size and forecast
  6.4.5 India market size and forecast
  6.4.6 South Korea market size and forecast
  6.4.7 Taiwan market size and forecast
  6.4.8 Other Asia-Pacific market size and forecast
6.5 LAMEA
  6.5.1 LAMEA digital pathology market
  6.5.2 Brazil market size and forecast
  6.5.3 Turkey market size and forecast
  6.5.4 Venezuela market size and forecast
  6.5.5 Saudi Arabia market size and forecast
  6.5.6 Colombia market size and forecast
  6.5.7 Argentina market size and forecast
  6.5.8 Other LAMEA market size and forecast

CHAPTER 7 COMPANY PROFILES

7.1 Visiopharm
  7.1.1 Company Overview
  7.1.2 Company Snapshot
  7.1.3 Operating Business Segments
  7.1.4 Key Strategic Moves & Developments
  7.1.5 SWOT Analysis
7.2 Indica Labs
  7.2.1 Company Overviewlogy, toxicological pathology, and more.
  7.2.2 Company Snapshot
  7.2.3 Operating Business Segments
  7.2.4 Key Strategic Moves & Developments
  7.2.5 SWOT Analysis
7.3 Digipath Inc.
  7.3.1 Company Overview
  7.3.2 Company Snapshot
  7.3.3 Operating Business Segments
  7.3.4 Key Strategic Moves & Developments
  7.3.5 SWOT Analysis
7.4 Koninklinje Philips N.V.
  7.4.1 Company Overview
  7.4.2 Company Snapshot
  7.4.3 Operating Business Segments
  7.4.4 Business Performance
  7.4.5 Key Strategic Moves & Developments
  7.4.6 SWOT Analysis
7.5 Hamamatsu Photonics K.K.
  7.5.1 Company Overview
  7.5.2 Company Snapshot
  7.5.3 Operating Business Segments
  7.5.4 Business Performance
  7.5.5 Key Strategic Moves & Developments
  7.5.6 SWOT Analysis
7.6 PerkinElmer, Inc.
  7.6.1 Company Overview
  7.6.2 Company Snapshot
  7.6.3 Operating Business Segments
  7.6.4 Business Performance
  7.6.5 Key Strategic Moves & Developments
  7.6.6 SWOT Analysis
7.7 Danaher Corporation (Leica Microsystem)
  7.7.1 Company Overview
  7.7.2 Company Snapshot
  7.7.3 Operating Business Segments
  7.7.4 Business Performance
  7.7.5 Key Strategic Moves & Developments
  7.7.6 SWOT Analysis
7.8 Nikon Corporation
  7.8.1 Company Overview
  7.8.2 Company Snapshot
  7.8.3 Operating Business Segments
  7.8.4 Business Performance
  7.8.5 Key Strategic Moves & Developments
  7.8.6 SWOT Analysis
7.9 Pixcelldata Ltd.
  7.9.1 Company Overview
  7.9.2 Company Snapshot
  7.9.3 Operating Business Segments
  7.9.4 Key Strategic Moves & Developments
  7.9.5 SWOT Analysis
7.10 Glencoe Software Inc.
  7.10.1 Company Overview
  7.10.2 Company Snapshot
  7.10.3 Key Strategic Moves & Developments
  7.10.4 SWOT Analysis
7.11 Definiens AG
  7.11.1 Company Overview
  7.11.2 Company Snapshot
  7.11.3 Key Strategic Moves & Developments
  7.11.4 SWOT analysis

List Of Figures

LIST OF FIGURES

Fig. 1 TOP IMPACTING FACTORS, BASE CASE SCENARIO (2022–2027)
Fig. 2 TOP IMPACTING FACTORS, RAPID GROWTH SCENARIO (2022–2027)
Fig. 3 TOP IMPACTING FACTORS, DIMINISHING GROWTH SCENARIO (2022–2027)
Fig. 4 DIGITAL PATHOLOGY MARKET DEFINITION
Fig. 5 TOP WINNING STRATEGIES IN THE DIGITAL PATHOLOGY MARKET (2013–2016)
Fig. 6 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2013–2016)
Fig. 7 TOP INVESTMENT POCKETS, BY PRODUCT
Fig. 8 TOP INVESTMENT POCKET BY END USER
Fig. 9 PORTER’S FIVE FORCES ANALYSIS
Fig. 10 TOP IMPACTING FACTORS: DIGITAL PATHOLOGY MARKET (2014–2022)
Fig. 11 DIGITAL PATHOLOGY WORKFLOW
Fig. 12 STORAGE WORKFLOW
Fig. 13 CLOUD STORAGE SYSTEM
Fig. 14 U.S. DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 15 CANADA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 16 MEXICO DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 17 GERMANY DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 18 FRANCE DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 19 U.K. DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 20 ITALY DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 21 SPAIN DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 22 RUSSIA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 23 OTHER EUROPE DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 24 JAPAN DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 25 CHINA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 26 AUSTRALIA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 27 INDIA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 28 SOUTH KOREA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 29 TAIWAN DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 30 OTHER ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 31 BRAZIL DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 32 TURKEY DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 33 VENEZUELA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 34 SAUDI ARABIA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 35 COLOMBIA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 36 ARGENTINA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 37 OTHER LAMEA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Fig. 38 VISIOPHARM - SWOT ANALYSIS
Fig. 39 INDICA LABS - SWOT ANALYSIS
Fig. 40 DIGIPATH INC - SWOT ANALYSIS
Fig. 41 PHILIPS HEALTHCARE: NET SALES, 2013–2015 ($MILLION)
Fig. 42 PHILIPS HEALTHCARE: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
Fig. 43 KONINKLINJE PHILIPS N. V.: REVENUE, BY GEOGRAPHY, 2015 (%)
Fig. 44 KLONINKINJE PHILIPS N.V. - SWOT ANALYSIS
Fig. 45 HAMATSU PHOTONICS K.K.: NET SALES, 2013–2015 ($MILLION)
Fig. 46 HAMATSU PHOTONICS K.K.: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
Fig. 47 HAMAMATSU PHOTONICS K.K. - SWOT ANALYSIS
Fig. 48 PERKINELMER, INC.: NET SALES, 2013–2015 ($MILLION)
Fig. 49 PERKINELMER INC.: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
Fig. 50 PERKINELMER INC.: REVENUE, BY GEOGRAPHY, 2015 (%)
Fig. 51 PERKINELMER INC. - SWOT ANALYSIS
Fig. 52 DANAHER: NET SALES, 2013–2015 ($MILLION)
Fig. 53 DANAHER: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
Fig. 54 DANAHER: REVENUE, BY GEOGRAPHY, 2015 (%)
Fig. 55 DANAHER - SWOT ANALYSIS
Fig. 56 NIKON: NET SALES, 2013–2015 ($MILLION)
Fig. 57 NIKON: REVENUE, BY BUSINESS SEGMENT, 2015 (%)
Fig. 58 NIKON: REVENUE, BY GEOGRAPHY, 2015 (%)
Fig. 59 NIKON - SWOT ANALYSIS
Fig. 60 PIXCELLDATA LTD. - SWOT ANALYSIS
Fig. 61 GLENCOE SOFTWARE INC - SWOT ANALYSIS
Fig. 62 DEFINIENS - SWOT ANALYSIS

List Of Tables

LIST OF TABLES

Table 1 GLOBAL DP PRODUCTS MARKET BY GEOGRAPHY, 2014–2022 ($MILLION)
Table 2 WORLD DP BASE CASE SCENARIO MARKET, BY GEOGRAPHY, 2022–2027 ($MILLION)
Table 3 WORLD DP RAPID GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022–2027 ($MILLION)
Table 4 WORLD DP DIMINISHING GROWTH SCENARIO MARKET, BY GEOGRAPHY, 2022–2027 ($MILLION)
Table 5 GLOBAL DIGITAL PATHOLOGY MARKET, BY PRODUCT, 2014–2022 ($MILLION)
Table 6 WHOLE SLIDE IMAGING SCANNERS BY VARIOUS COMPANIES
Table 7 GLOBAL DIGITAL PATHOLOGY WHOLE SLIDE IMAGING MARKET, BY PRODUCT, 2014–2022 ($MILLION)
Table 8 GLOBAL DIGITAL PATHOLOGY WHOLE SLIDE IMAGING MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
Table 9 IMAGE ANALYSIS SOFTWARE BY VARIOUS COMPANIES
Table 10 GLOBAL DIGITAL PATHOLOGY IMAGE ANALYSIS—INFORMATICS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
Table 11 GLOBAL DIGITAL PATHOLOGY INFORMATION MANAGEMENT SYSTEM, STORAGE & COMMUNICATION MARKET, BY GEOGRAPHY, 2014-2022 ($MILLION)
Table 12 GLOBAL DIGITAL PATHOLOGY OTHERS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
Table 13 GLOBAL DIGITAL PATHOLOGY MARKET, BY END USER, 2014–2022 ($MILLION)
Table 14 GLOBAL DIGITAL PATHOLOGY MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
Table 15 GLOBAL DIGITAL PATHOLOGY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
Table 16 GLOBAL DIGITAL PATHOLOGY HOSPITALS AND DIAGNOSTIC CENTERS MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
Table 17 GLOBAL DIGITAL PATHOLOGY EDUCATIONAL INSTITUTES MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
Table 18 WORLD DIGITAL PATHOLOGY MARKET, BY GEOGRAPHY, 2014–2022 ($MILLION)
Table 19 NORTH AMERICA DIGITAL PATHOLOGY MARKET, 2014–2022 ($MILLION)
Table 20 EUROPE DIGITAL PATHOLOGY MARKET, 2014–2022 ($MILLION)
Table 21 ASIA-PACIFIC DIGITAL PATHOLOGY MARKET, 2014–2022 ($MILLION)
Table 22 LAMEA DIGITAL PATHOLOGY MARKET, 2014-2022 ($MILLION)
Table 23 VISIOPHARM - COMPANY SNAPSHOT
Table 24 VISIOPHARM - OPERATING SEGMENTS
Table 25 INDICA LABS - COMPANY SNAPSHOT
Table 26 INDICA LABS - OPERATING SEGMENTS
Table 27 DIGIPATH INC - COMPANY SNAPSHOT
Table 28 DIGIPATH CORPORATION - OPERATING SEGMENTS
Table 29 KONINKLINJE PHILIPS N. V. - COMPANY SNAPSHOT
Table 30 PHILIPS HEALTHCARE - OPERATING SEGMENTS
Table 31 HAMAMTSU PHOTONICS K. K. - COMPANY SNAPSHOT
Table 32 HAMAMTSU PHOTONICS K.K. - OPERATING SEGMENTS
Table 33 PERKINELMER INC. - COMPANY SNAPSHOT
Table 34 PERKINELMER INC. - OPERATING SEGMENTS
Table 35 DANAHER - COMPANY SNAPSHOT
Table 36 DANAHER - OPERATING SEGMENTS
Table 37 NIKON - COMPANY SNAPSHOT
Table 38 NIKON - OPERATING SEGMENTS
Table 39 PIXCELLDATA LIMITED- COMPANY SNAPSHOT
Table 40 GLENCOE SOFTWARE - COMPANY SNAPSHOT
Table 41 DEFINIENS - COMPANY SNAPSHOT